Poïesis Populates Pipeline with Investment the Missing Link

Poïesis Populates Pipeline with Investment the Missing Link

By Joseph Harvey, Editor, March 15, 2018 US companion animal medicines firm Poïesis Therapeutics is now working on in-licensing a pipeline of eight candidates from human biotechnology companies. The San Diego-based business is looking to develop a range of potential...
Poïesis Opens Seed Round Seeking $5 Million

Poïesis Opens Seed Round Seeking $5 Million

Following on its move from London to San Diego, California, Poïesis has opened its Seed Round of financing seeking to raise $5 million to complete in-licensing and initiate clinical development of its therapeutic and diagnostic pipeline in several indications in dogs,...
Three Trends That Will Transform Animal Health

Three Trends That Will Transform Animal Health

By Michael Helmstetter, Ph.D., President and CEO, TechAccel, July 27, 2017.  Many investors who are interested in the animal health space still feel they don’t know the industry well enough to make smart investments. The feeling is understandable. Animal health is an...
Why Pet Health Is The Focus Of A New Biotech Sector

Why Pet Health Is The Focus Of A New Biotech Sector

By Cathy Yarbrough, Contributing Editor   For Aratana Therapeutics, 2016 was a banner year. The biotech company, founded in 2010, achieved FDA approvals for three of its 10 pipeline drugs. Last year the Kansas City-based company also forged a global partnership with...